S. Wang

P632 Vedolizumab dose escalation in patients with inflammatory bowel disease experiencing loss of response: A systematic review and meta-analysis of real-world evidence

M. Luo, D. Varghese, D. Patel, 2020 .

Ibrutinib As Treatment for Chemoimmunotherapy-Resistant Patients with Follicular Lymphoma: First Results from the Open-Label, Multicenter, Phase 2 DAWN Study

G. Salles, S. Schuster, J. Vermeulen, 2016 .

P267 Sequencing of anti-TNF agents and gut-selective anti-lymphocyte trafficking (GSALT) therapy in the treatment of Crohn’s disease (CD)

P. Kamble, Y. Ba, Z. Huang, 2021 .